Eric K. Neumann is founder and co-chair for the W3C Semantic Web Healthcare and Life Science Interest Group (HCLSIG) that is bringing together industry leaders to identify domain-specific applications that will benefit from Semantic Web technologies. He was also a Senior Strategist for Teranode Corporation, a company developing next generation systems for pharmaceutical companies. He also has formed the Clinical Semantics Group, a consultancy group specializing in the development of intelligent applications for clinical trials informatics. Prior to this, Dr. Neumann was Global Head of Knowledge Management for Scientific and Medical Affairs within Sanofi-Aventis, covering all of global R&D. He has also developed the first Drug Discovery Semantic Web dashboard called BioDash. He has also held top positions at Beyond Genomics, Netgenics, and Bolt, Beranek, and Newman. Dr. Neumann is an expert in knowledge-based methods for the pharmaceutical industry, and has been in the biotechnology industries for the past 16 years.
Dr. Neumann holds an undergraduate degree from the Massachusetts Institute of Technology, and a PhD in neurobiology and developmental genetics from Case Western University.
